Imnovid (previously Pomalidomide Celgene)-H-C-PSUSA-00010127-201502
Pharmazeutisch
Imnovid (previously Pomalidomide Celgene)-H-C-PSUSA-00010127-201502
Fortschrittliche pharmazeutische Formulierung für gezielte therapeutische Intervention.
Dosierung
Imnovid (previously Pomalidomide Celgene)-H-C-PSUSA-00010127-201502
Stärke
Imnovid (previously Pomalidomide Celgene)-H-C-PSUSA-00010127-201502
Packungsgröße
Imnovid (previously Pomalidomide Celgene)-H-C-PSUSA-00010127-201502
Form
Imnovid (previously Pomalidomide Celgene)-H-C-PSUSA-00010127-201502
Quelle
European Medicines Agency
Sicherheitsprofil
Kontraindikationen
Imnovid (previously Pomalidomide Celgene)-H-C-PSUSA-00010127-201502
Nebenwirkungen
Imnovid (previously Pomalidomide Celgene)-H-C-PSUSA-00010127-201502
